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There is a need for better communication between people involved in public-
health issues, of which I am one, and representatives of the food industry. My
objective here is to initiate the kind of dialog that I feel is necessary on public-
health nutrition issues and how they relate to agricultural biotechnology and
food production.
By way of background, I will discuss the current disease burden in the United
States and globally, and public-health objectives and approaches: as public-
health workers, what are we trying to achieve with health and how does that
relate to food? Then I will discuss how food technology makes our lives as
public-health people better on one hand and makes it worse on the other. Some
implications for the food supply are noteworthy, based on a presentation at a
World Health Organization/Food and Agriculture Organization (WHO/FAO)
Consultation on Diet, Nutrition, and Chronic Diseases, Geneva, Switzerland,
in␣ January 2002, in which I participated. And I will conclude with policy
implications and research needs, from my perspective.
CURRENT DISEASE BURDEN
An article by Michael McGinnis, formerly the Deputy Assistant Secretary for
Health, and Bill Foege, who was at the Centers for Disease Control (CDC),
Atlanta, and also was President of the American Public Health Association, is
often cited to establish that most deaths are now related to modifiable “lifestyle”
factors: tobacco, alcohol, diet, and other personal behaviors (McGinnis and
Foege, 1993). This picture of chronic disease is increasingly applicable globally,
as shown by the Global Burden of Disease report (Murray and Lopez, 1996),
which was a topic of much discussion at the January 2002 WHO/FAO meeting.
Heart disease is now the most prevalent ailment globally, i.e. for developing
as␣ well as for developed countries. Although communicable diseases remain
important in developing countries, they kill fewer people than non-communi-
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cable or chronic diseases. Even in regions where there are food shortages, and
people continue to strive for survival, some are dying from heart disease and
diabetes. It is projected that, by 2025, most of the people affected by chronic
diseases will be outside the United States, i.e. in India, China, the Russian
Federation, Japan, Pakistan, and Indonesia.
Attempts have been made to calculate how much of the United States
healthcare budget is devoted to conditions such as obesity. In 1995 dollars,
type-2 diabetes cost about $50 billion, for example. Some 5 to 8% of the
national health care budget is spent on obesity-related diseases—a huge fraction
for one condition, and it is probably an underestimate. In Australia it is over
2%, and 4% in the Netherlands and France. In developing countries in which
healthcare budgets are small, and where diabetes is emerging, as much as 25%
of the healthcare budget is being spent treating complications like end-stage
renal disease. In such countries, there is potential for overwhelming effects of
chronic diseases. Therefore, there is need to deal with these conditions even
where there is need to get food to the hungry.
The latest data, for 1999, from the CDC website, show continuing increasing
trends in obesity, including children in the 6 to 11 and 12 to 18 age groups. It
is␣ to be expected that 5% would be above the ninety-fifth percentile standard;
instead 14 or 15% are above it, and this does not include the children who are
considered to be at risk of being overweight, i.e. up to 30% of some popula-
tions. Not only does childhood obesity often lead to adult obesity, it is
associated with problems during childhood.
The burden is not evenly distributed by ethnicity and income status;
6-to␣ 11-year-old black girls were no more obese than white girls in the 1950s,
whereas they were more likely to be above the ninety-five percentile in 1994
data, and a similar trend is seen in Hispanic girls. There is more obesity and
more chronic disease within some minority populations than in the general
population. For death rates, the excess shows up primarily in African
Americans. Deaths per 100,000 population for heart disease and cancer are
higher for blacks, whereas other minority groups have lower rates than for
the␣ white population. This indicates ethnicity-linked protective factors. One
of␣ our goals, from a public-health perspective, is to elucidate and preserve the
factors that contribute to lower death rates—to understand why these groups
have not acquired all of the risk factors in these diseases, at least to the point
of␣ mortality.
For heart disease and cancer, similar patterns by ethnicity are seen for men
and women. For diabetes, Asian Americans are the only group with rates lower
than for whites. More years of potential life are lost from diabetes among
American Indians, Hispanics, and blacks compared to whites.
Finally, on disease burden, there is considerable low birth weight in this
country among black and Puerto Rican Americans, and the chronic-disease-risk
profile now includes this factor. The concept is that something happens in utero
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to compromise an adequate pattern of growth. Children are born small, and,
although they may gain weight rapidly, epidemiologically they remain at higher
risk for chronic diseases in adulthood. This was seen in the Dutch-famine and
in other studies leading to the “Barker hypothesis” or the “fetal-origins-of-
disease” hypothesis. We are still trying to elucidate the reasons why low
birth-weight due to undernutrition during pregnancy results in a predisposition
in certain communities to chronic diseases later in life.
PUBLIC HEALTH PERSPECTIVE ON DIET
The task of the public-health worker is to prevent and control disease.
Anything in the system that appears to cause or aggravate disease is a possible
focus for intervention. We are also responsible for positioning these issues in
the larger discussion: in my work, I am interested in engaging those whose
work has effects on what people eat or how active they are, or on other aspects
of their health, e.g. urban planners, bus route planners, bankers. The role of the
public-health scientist is to show that everything in the system is connected:
apparently unrelated activities can have unexpected repercussions in terms of
adverse effects on the health of the population. We are trying harder to quantify
relative impact in order to allot priority in terms of numbers of people affected
as well as severity. We are advocating for an objective policy process, i.e. to
prevent vested interests from unduly influencing the policy process. I was at
the␣ infamous release of dietary guidelines when Secretary Glickman had a pie
thrown in his face; part of the concern thus expressed was that vested interests
had been influential. The only vested interest entering the policy process
should be that of protecting vulnerable populations. We need to be one step
removed when we are setting policy.
How do we set dietary guidelines? We try to keep track of everything—what
people eat and how it affects their health—i.e. the nutrition-monitoring system
that is now endangered because of lack of funds. We try to track food and
where it is eaten, we set nutrient requirements, measure health outcomes,
monitor consumer behavior, etc. With the appropriate data, we can monitor
downstream effects of various choices, both in terms of industry activity and
in␣ terms of consumer behavior. It is complicated, especially when teaching
epidemiology students, because it involves not just what is eaten but also host-
specific factors. Whether supplements are being taken and in what forms and
whether a nutrient needs activation all influence what doses people are getting
and the ultimate health effects. It becomes a complicated process also from the
conceptual and causal-model points of view; our data are seldom precise, and
we are never quite sure whether an apparent effect is real or not.
We are now using an outcomes-based approach for devising dietary
guidelines. Formerly, the approach was to look at whether intake seemed to
be␣ low or high based on our best data, and then examine evidence linking the
nutrient to a particular disease or other adverse effects associated with intake at
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that level. If there were possible adverse effects then we would track them, and
if we could confirm them then we would change the level in the food supply,
increase it or decrease it to alleviate the risk. However, there are too many
components in the food supply. Going nutrient by nutrient, even with just fifty
items to track, rapidly becomes too ponderous. Therefore, as we obtain better
data—in the United States and in other countries, and the WHO is now using
this approach—we can start with disease outcomes. Heart disease, diabetes,
obesity, cancer, osteoporosis, and bone and dental diseases were most recently
addressed by the aforementioned WHO/FAO diet and disease consultation. We
then look at how convincing is the evidence that appears to associate a disease
with food intake. If it is convincing, if it is a definite public-health/nutrition
issue, we make a recommendation to increase or decrease intake. If it is
probable, a potential issue, and we are not quite sure—food changes are
considered to be harmless compared to, say, drugs with which physiological
effects are unknown—any recommendation to increase or decrease intake
would not be made aggressively, but offered as advice. And then, if there is no
evidence of a pattern, e.g. with coffee—although past studies have proven
negative—there may still be a potential research issue. As long as consumers or
scientists think that there is potential for harm, we keep studying it. And when
something new comes on the market, even in the absence of apparent adverse
effects it will be a potential research issue, but, without evidence of disease, no
effort will be expended to affect intake.
As an aside: intake is likely to change. If one item is modified because of
convincing evidence, then it will shift at least part, if not all, of the dietary
pattern. Also, intake may change unexpectedly because of alterations in the
food supply. Again, it is difficult to draw sound conclusions from such
complexity.
The type of evidence we obtain contrasts with data that are generated in
controlled experiments. We seek ecological validity for human populations
rather than for small numbers of individuals in a laboratory setting. We glean
ideas by comparing countries or by following people over time and by seeking
patterns in retrospect in those afflicted with disease, having examined what
they were eating. In clinical trials we investigate whether changing that
component of the diet has the desired effect. Then larger-scale trials are
conducted before we consider new policy; simultaneous studies in the lab
examine mechanisms to elucidate what should be tested in the trials.
To decide whether an association is causal, however—because it is not
laboratory based—we use logic, graded logic, to determine if we have
consistent, unbiased, strong, coherent, repeated, predictive, and plausible
evidence. Although such firm evidence is seldom obtained, areas of relative
certainty exist. We assign importance to relative risk; we are most concerned
about factors that have large effects on people with diseases, but small effects
on a lot of people are also of great concern.
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The World Cancer Research Fund Panel published a comprehensive
coverage␣ of studies that attempted to relate cancer to diet up to 1997, and
the␣ evidence rules that they used with slight modification were also those
used␣ in the WHO/FAO report referred to above. In the strongest category
there␣ is consistency, with strong laboratory support and evidence of a dose-
response, e.g. the more fruit and vegetables you eat the better off you are
compared to people who eat less or none. In the “probable” category, there
is␣ less consistency, possibly resulting from fewer studies, but there is strong
mechanistic or laboratory support. Then there is the “possible” category,
which␣ is generally supportive but␣ no firm conclusion is possible. Lastly, in
the␣ “insufficient” category are issues that have public appeal, but no supporting
evidence; they may garner media coverage but there is no persuasive reason
for␣ formal study.
The following are common themes, and areas in which we feel secure: calorie
intake should be controlled, correct energy balance maintains weight, fat and
cholesterol should be limited, a variety of plant foods have positive effects, and
moderation in intake of sugar and salt is important, as are adequate physical
activity, alcohol in moderation and avoidance of smoking. A conference was
convened in 1997 (Preventive Nutrition: Pediatrics to Geriatrics in Salt Lake City,
Utah by the Nutrition Committee of the American Heart Association, with
invitees from the American Cancer Society, Diabetes Association, Dietetic
Association, National Institutes of Health, American Academy of Pediatrics,
and␣ the USDA Dietary Guidelines) to discuss targets for change in the American
diet (Deckelbaum et al., 1999). At first, some of the commonality that emerged
was thought to be coincidental, but, as more data are obtained, a convergence
is␣ emerging in mechanisms causing various diseases once considered to be very
different. For example, at the time the conference was held, insulin resistance
was not known to be related to cancer, but much data now indicate a link.
Inflammation was thought to be strictly of infectious or other origin, but now
it␣ is understood to be linked to the atherosclerotic pathway. And apoptosis
related to cancer is now understood to be related also to diabetes and
atherosclerosis. So, it could be that one set of physiological processes, variously
expressed in individuals with different predispositions or different exposures,
leads to different diseases.
What is wrong with this approach? First of all, it is essentially outside the
agricultural sector. So new recommendations on dietary guidelines are made
with no knowledge of implications for the food supply, which has global
implications. This type of public-health approach should be taken in conjunc-
tion with people in the production sector. Also, this perspective on food is very
different from that of the consumer. We look at food as a carrier of risk,
whereas few people sit down at the table thinking they that they are partaking
of risk factors, or in the supermarket feel a need to minimize risk factors as they
shop for food. Our reductionist chemical perspective is difficult to communi-
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cate to consumers. In large part, our approach still emphasizes individual
diseases and is simplistic with respect to dietary interactions. Epidemiology is
very bad at handling interactions: we need broad control in order to investigate
one part, even though in nature it is impossible to control one component that
is influenced by others. It is also non-experimental because that is the only
means of investigating natural scenarios in human populations, therefore, we
can never be sure about cause. And a long lag-time is necessary for definitive
answers; suspicion over a new addition to the food supply is likely to require
thirty or forty years before it is proven to be justified, or not.
FOOD TECHNOLOGY
Food technologists are addressing many of these issues, but outside of the
public-health sector. There are unlimited possibilities, which is problematical
from a study-design point of view. When I assess diet I have no idea what I am
looking for in the population, because the many new variables that are entering
the food supply are changing our bases for risk assessment.
Furthermore—a pet peeve of mine—the health-based marketing of single
foods is not really consonant with dietary guidance, because we are moving
more towards patterns. The emphasis on health effects from single foods is
making life more difficult, because consumers have the tendency to look for
magic bullets, as some claims seem to promise.
FOOD SUPPLY
From a food-supply perspective, let’s consider the United Kingdom, where most
people are not meeting dietary guidelines—e.g. very few, especially women,
meet the guidelines for fat or fiber—and also consider that huge changes are
taking place in countries like China because of the globalization of the food
supply. A model developed by the International Obesity Task Force, the policy
and advocacy arm of the International Society for the Study of Obesity
(London) gives ideas on how links between global markets and development
factors and advertising reach across national boundaries effect changes. It
becomes very difficult to devise generally applicable methods to elicit change.
Prakash Shetti at the Food and Agriculture Organization, addressing the
WHO/FAO consultation, posed the question of whether, in recommending 400
g of fruits and vegetables per day, anybody had multiplied the global population
by 400 to see if enough fruits and vegetables are actually available? Can dietary
guidelines be met without talking to producers? Also, he pointed out that 80%
of fish imports are to Japan, the United States and the European Community; a
third of the catches from developing countries enter international trade,
supplying 50% of total exported fish. We may be creating a situation with
dietary guidelines in which we take food from developing countries so that we
can have the right amounts of fish and fruits and vegetables in affluent
countries. These issues need careful consideration.
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It is difficult to predict trends in consumer preferences. Even with intense
advertising campaigns, it is hard to tell if consumers will accept something
different in the diet. An analysis of national-survey data between 1965 and 1991
by Barry Popkin documented changes in whites and blacks for fiber products,
pasta, etc. For example, blacks increased their high-fiber cereal consumption by
1,500%, whereas whites increased theirs by a smaller amount. In some cases,
trends for blacks and whites were in opposite directions. When the food supply
changes, we still cannot predict long-term effects.
POLICY AND RESEARCH ISSUES
Top-down strategies are being discussed, making some people uneasy because
they conflict with the free-market ethic. Finland, for example, has successfully
instituted such a strategy, although it requires community involvement,
including cooperation from people who resist regulation and who object to the
government telling them what to do. Certainly, integration and harmonization
of public-health strategies with the food industry are essential. Having drawn
up dietary guidelines, integration of agricultural and public-health policies
becomes necessary. However, when agricultural policy is being set, improve-
ment in public health is not a chief objective; clearly, coordinated policy
development is needed.
With the top-down approach, there is less reliance on consumer education
than hitherto. In the Finnish example, high rates of cardiovascular disease
were␣ reversed by environmental changes, with taxation and other strategies
that␣ did not rely only on direct appeals to individuals to change their behavior.
Technology played a key role in developing a locally adapted rapeseed oil. The
concept of a cholesterol-lowering oil produced domestically gained popular
acceptance. The reductions in chronic heart-disease rates over a 25-year period
are well documented—not merely through improved treatment (as here in the
US), but by significantly reducing new cases. Dr. Pekka Puska, who led this
successful program in Finland, is now with the WHO leading a global effort to
reduce rates of heart disease (Puskka, 2000).
What are the implications of agricultural biotechnology for dietary guidance?
If the food supply changes as a result of genetic engineering, we need to blend
those changes with dietary guidance. This morning, my orange-juice carton
indicated a calcium content equal to that in milk. Nutrients that were here are
now also there. This may be good, but how does it affect the food pyramid? We
need to forecast trends and consumer reactions with which to match the
guidelines. Clearly, we need to study not only what people are eating and what
is in the food, but, especially, shifts in food intake and particularly in vulnerable
populations.
And finally, regarding environmental issues: in fact, there is very little
understanding of how to change the environment in a way that would be
beneficial for both producers and consumers with respect to diet and health.
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